ArticleTargeted oncology2021

The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment.

Pina Ziranu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.